<DOC>
	<DOC>NCT00083434</DOC>
	<brief_summary>The purpose of this study is to examine the effectiveness of epoetin alfa in treating anemia in patients who have cancer or who no longer have any signs of the cancer, but remain anemic as a result of their treatment.</brief_summary>
	<brief_title>Treatment of Anemic Patients With Cancer Who Are Not Receiving Chemotherapy or Radiotherapy</brief_title>
	<detailed_description />
	<mesh_term>Epoetin Alfa</mesh_term>
	<criteria>18 years of age or older Body weight &gt;/= 99lbs ECOG 02 Anemia results from cancer, chemotherapy, radiotherapy or an association with hormonal therapy or immunotherapy Screening hemoglobin level of &lt;/= 11.0 g/dL for men or &lt;/= 10.0 for women History of or concurrent second malignancy Evidence of primary or metastatic malignancy involving the Central Nervous System</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2011</verification_date>
	<keyword>Anemia</keyword>
	<keyword>Cancer</keyword>
</DOC>